Veenat 100 Mg Capsule contains the active ingredient imatinib mesylate. This works by inhibiting the activity of specific tyrosine kinases, including BCR-ABL, c-KIT, and PDGF-R, which are involved in the abnormal growth and proliferation of cancer cells. By blocking these kinases, imatinib helps to inhibit the growth of cancer cells and induce their death. It is a tyrosine kinase inhibitor used in the treatment of various types of cancer, including chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and gastrointestinal stromal tumors (GISTs). Veenat 100 Mg Capsule is usually taken orally, once or twice daily, with a meal and a full glass of water.
Specification
Brand |
Veenat |
Dose/Strength |
100 mg |
Packaging Type |
Stripe |
Shelf Life |
24 month |
Usage/Application |
Hospital |